AI Just Made CT Scans Controversial Again

Hey there, welcome to "Beyond the Scan"! I'm Jackie, your host, and I'm so glad you're joining me today, Friday, April 18, 2025.

Quick shoutout to our sponsor RadiologyJobs.com—they're doing amazing work connecting imaging professionals with great opportunities nationwide.

I've got some really exciting stories to share with you today! First, we'll be discussing Nanox getting FDA clearance for a new imaging system. Then, we'll explore the American College of Radiology criticizing a prominent study claiming CT imaging causes cancer. Next, we'll dive into Elumina Health announcing the launch of a new AI capability in BasisEHR. And finally, we'll wrap up with Analog Devices’ 2025 General Technical Conference highlighting healthcare innovation. I'm really excited to dive into these stories with you because they're all showing us where healthcare is headed. I think you'll be particularly interested in our main story about Nanox getting FDA clearance for a new imaging system, which I found absolutely fascinating when I was researching for today's episode.

So, let's kick things off with that first story. You know what's really exciting? Nanox just got FDA clearance for its new imaging system, the Nanox.ARC X! This system is a multi-source digital tomosynthesis platform that’s designed to produce 3D images for all sorts of uses, like musculoskeletal, pulmonary, and abdominal imaging. The fact that they got this clearance in under 30 days is pretty remarkable—one of the fastest reviews for medical imaging hardware! Erez Meltzer, the CEO, highlighted that this advancement makes it easier for healthcare providers to adopt digital 3D imaging, which is a game changer in expanding access to advanced medical imaging.

Now, why does this matter so much? Traditional 2D X-rays can be pretty limited. They often have issues with structural superimposition, which can make diagnosis tricky. But with the Nanox.ARC X, they’re using 15 to 30 digital X-ray sources to create those amazing sliced 3D images. Plus, the compact design means it can fit into tight spaces like urgent care centers or rural hospitals—places that really need better imaging options. You know, it’s all about making advanced imaging accessible where patients need it most. It even maintains radiation doses comparable to standard X-rays thanks to its cool cold cathode technology. Isn’t that amazing?

I was really blown away by the clinical benefits as well. Studies show that it improves fracture detection, especially in challenging scenarios, like with obese patients. With a cable-free design that can work in regular X-ray rooms, it’s a big leap forward. I mean, this isn’t just about getting better images—it’s about making sure that more people can access the care they need. The company plans to roll it out commercially later this year, and I can’t wait to see how it’ll impact patient care!

Now, let’s shift gears and talk about our next story. The American College of Radiology, or ACR, has come out swinging against a recent study published in *JAMA Internal Medicine*. This study claimed that 2023 CT scans could lead to about 103,000 future cancers. The ACR is calling this risk theoretical and unproven, which is pretty significant. They argue that the study’s estimates are based on statistical models and don’t reflect actual patient outcomes. How often do we see these kinds of debates in our field, right?

CT scans play such a crucial role in modern medicine. They’ve helped reduce cancer mortality rates significantly by enabling early detection and avoiding invasive procedures. But with CT use on the rise, it’s essential to balance the benefits against the theoretical risks. The ACR has been proactive in promoting initiatives like Image Gently and the Dose Index Registry, which aim to optimize radiation doses and reduce unnecessary imaging. You know, it’s all about ensuring that the benefits clearly outweigh the risks, and the ACR is really at the forefront of this conversation.

Critics of the *JAMA* study, including lead author Rebecca Smith-Bindman, stand by their findings, but many clinicians emphasize the lifesaving value of CT imaging. As Dr. Richard Reitherman pointed out, the known benefits of CT scans—like shorter hospital stays—must be weighed against the theoretical risks. And while the study projected specific cancers, the uncertainty in those estimates really raises questions about the methodology. The ACR is committed to working with policymakers to ensure that patients have access to high-quality imaging while also promoting informed discussions about risks with providers.

Moving on to our next story, let’s talk about Elumina Health. They just announced the launch of a new AI capability in their BasisEHR platform, and it’s designed for home healthcare. This new feature uses AI to analyze patient data, helping to identify individuals at high risk of hospitalization. It’s such a smart move, especially considering the challenges in home healthcare. Dr. Sreeram Mullankandy from Elumina mentioned that traditional EHR systems often fall short in this area, but with this new capability, clinicians can prioritize monitoring and interventions better than ever before.

You know, this is super relevant because home healthcare is growing rapidly. Elumina has seen a tenfold increase in patient volumes over the past three years, which really highlights the need for solutions tailored to these unique workflows. By automating clinical documentation and risk stratification, BasisEHR helps to reduce the administrative load on clinicians. And let’s face it, anything that can help reduce readmissions in post-acute care is a win for everyone involved!

What’s fascinating is how seamlessly this AI integrates into existing workflows. It generates real-time risk scores without interrupting the provider’s routine, which is crucial. Clinicians have really taken to the platform, noting that it improves care coordination compared to older systems. Dr. Mullankandy pointed out that their team in Columbus is proving that focused innovation doesn’t have to come from major tech hubs. This kind of ingenuity can happen anywhere, which is such an encouraging thought for those of us in the field.

And finally, let’s dive into Analog Devices’ 2025 General Technical Conference, where they highlighted some incredible advancements in healthcare innovation. Berta Marti Fuster showcased collaborations that are pushing the boundaries of medical imaging and AI-driven diagnostics. It’s exciting to see nearly 2,000 participants come together to explore scalable technologies that can transform remote healthcare. Berta emphasized how these partnerships can really redefine what’s possible in healthcare, which is just so inspiring.

We’re also seeing a rise in wearable technologies, like the FDA-cleared Sensinel system, which allows for home-based monitoring of chronic conditions. This aligns perfectly with trends in decentralized clinical trials, where wearables are making it easier to collect continuous data. I mean, capturing real-time physiological metrics can lead to earlier clinical interventions, which is a huge win for patient care!

The conference also highlighted the fusion of human expertise and AI, with examples like Stanford’s Swarm AI system that combines insights from radiologists with algorithmic support. This integration is so crucial for improving diagnostic accuracy. And with Analog Devices’ advancements in medical imaging, they’re really positioning themselves at the forefront of this healthcare revolution. The focus on interdisciplinary collaboration is key to addressing global health challenges.

Well, that's all we have for today's episode of "Beyond the Scan." I've really enjoyed sharing these developments with you.

You know, I was thinking about our main story today on Nanox getting FDA clearance for a new imaging system. It really shows how quickly our field is evolving, and I think it's the kind of development that could make a real difference in patient care. That's what I love about doing this podcast - we get to explore these advances together and think about how they'll shape our work.

If you found today's discussion helpful, I'd love it if you'd subscribe and share with your colleagues. And hey, swing by our website at beyondthescan.com where we've got some great additional resources on these topics.

I'll be back next week with more exciting updates. This is Jackie signing off, and remember—what we do really does make a difference in people's lives every day. Take care!